Shilpa Medicare launches third anti-cancer drug in India - (India Infoline via NewsPoints Desk)

  • Shilpa Medicare said it has launched an anti-cancer drug with the brand name Ibrushil in the Indian market, reported India Infoline.

  • This anti-cancer drug is used in the treatment of the patients suffering from chronic lymphocytic leukemia, mantle cell lymphomas and other related cancers.

  • According to the news source, this is the company's third launch of an anti-cancer drug in the Indian market, followed by the launch of lenvatinib and dasatinib.

To read more NewsPoints articles, click here.